Implementation of a drug-use and disease-state management program

Citation
Sj. Skledar et Mm. Hess, Implementation of a drug-use and disease-state management program, AM J HEAL S, 57(24), 2000, pp. S23-S29
Citations number
4
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
ISSN journal
10792082 → ACNP
Volume
57
Issue
24
Year of publication
2000
Supplement
4
Pages
S23 - S29
Database
ISI
SICI code
1079-2082(200012)57:24<S23:IOADAD>2.0.ZU;2-3
Abstract
A drug-use and disease-state management (DUDSM) program was instituted in 1 996 at a teaching hospital associated with a large nonprofit health care sy stem. The program's goals are to optimize pharmacotherapeutic regimens, evaluate health outcomes of identified disease states, and evaluate the economic imp act of pharmacotherapeutic options for given disease states by developing p ractice guidelines. Through a re-engineering process, resources within the pharmacy department were identified that could be devoted to the DUDSM prog ram, including the use of clinical pharmacy specialists, promotion of staff pharmacists into the DUDSM program, a pharmacy technician, and information systems support. A strength of the program is its systematic approach for developing and implementing new initiatives, as well as monitoring complian ce with all initiatives on an ongoing basis. The initiative-design process incorporates continuous quality improvement principles, outcome design and evaluation, competency assessment for all pharmacists, multidisciplinary co llaboration, and sophisticated information systems. Seventy-five initiative s have been implemented, ranging from simple dose-optimization strategies f or specific drugs to complicated practice guidelines for managing specific disease states. Improved patient outcomes have been documented, including r educed length of stay, postsurgical wound infection, adverse drug reactions , and medication errors. Documented cost savings exceeded $4 million annual ly for fiscal years 1996-97 through 1999-2000. Overall compliance with DUDS M initiatives exceeds 80%, and physician service profiling has been initiat ed to monitor variant prescribing. The DUDSM program has successfully integrated practice guidelines into ther apeutic decision-making, resulting in improved patient-care outcomes and co st savings.